Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

SZSE:002932 Stock Report

Market Cap: CN¥4.2b

Wuhan Easy Diagnosis BiomedicineLtd Past Earnings Performance

Past criteria checks 1/6

Wuhan Easy Diagnosis BiomedicineLtd has been growing earnings at an average annual rate of 13.9%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 21.3% per year.

Key information

13.9%

Earnings growth rate

13.0%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate21.3%
Return on equity-0.8%
Net Margin3.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SZSE:002932) Stock Rockets 26% But Many Are Still Ignoring The Company

Mar 07
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SZSE:002932) Stock Rockets 26% But Many Are Still Ignoring The Company

Revenue & Expenses Breakdown

How Wuhan Easy Diagnosis BiomedicineLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002932 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2434911286121
30 Jun 2436628302125
31 Mar 2443832283135
31 Dec 2375075304141
30 Sep 233,686515754340
30 Jun 235,8151,561824403
31 Mar 238,4152,895919393
01 Jan 2310,5304,208955388
30 Sep 228,3614,246441209
30 Jun 226,9423,594400140
31 Mar 224,6402,461345139
01 Jan 222,8301,413294133
30 Sep 212,2571,118233114
30 Jun 211,740848207100
31 Mar 211,60880817486
31 Dec 2095946912970
30 Sep 206823539347
30 Jun 204402017740
31 Mar 20163276436
31 Dec 19181426437
30 Sep 19184585936
30 Jun 19180635734
31 Mar 19186645630
31 Dec 18176615227
30 Sep 18180674724
30 Jun 18179703035
31 Mar 18172684731
31 Dec 17165653926
30 Sep 17154614218
30 Jun 1715863600
31 Mar 1713855410
31 Dec 1614160520
30 Sep 1613054490
30 Jun 1612048450
31 Mar 1610742390
31 Dec 159536330
30 Sep 158733280
30 Jun 157931220
31 Mar 156826200
31 Dec 145822180
30 Sep 144918160
30 Jun 144015130
31 Mar 143311110
31 Dec 13267100

Quality Earnings: 002932 has a large one-off gain of CN¥57.6M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 002932's current net profit margins (3%) are lower than last year (14%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002932's earnings have grown by 13.9% per year over the past 5 years.

Accelerating Growth: 002932's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 002932 had negative earnings growth (-98%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).


Return on Equity

High ROE: 002932's Return on Equity (-0.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 17:41
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution